Corcym

Corcym is a global medical device company specializing in structural heart disease, with expertise in heart valve prostheses and cardiac repair devices. The company manufactures a comprehensive portfolio of products including sutureless aortic valves (Perceval), mechanical heart valves (Carbomedics, Bicarbon, Orbis families), bioprosthetic aortic valves (CarboSeal Valsalva), and annuloplasty rings for mitral and tricuspid valve repair (Memo platform, Sovering flexible rings, HAART, TriMemo). Products are supported by solid clinical evidence and designed for surgical precision in structural heart interventions. Corcym holds FDA clearances (including recent TriMemo clearance in 2026 for tricuspid repair) and maintains regulatory approvals in multiple markets including China. The company provides healthcare professional education through Corcym Academy, offering training programs in aortic valve replacement with Perceval, annuloplasty techniques with Memo 4D, minimally invasive approaches, and robotic-assisted procedures. Corcym serves cardiac surgeons and heart surgery centers globally, with patient support programs, investigator-initiated research collaboration, and comprehensive product safety and device tracking systems. The organization emphasizes innovation in minimally invasive cardiac surgery and peer-to-peer clinical knowledge exchange through partnerships with scientific societies.